Feb. 15, 2021 – The Maryland House and Senate voted last week to override Gov. Larry Hogan’s May 2020 veto and enact the nation’s first tax on digital advertising, a move that other states are in the process of considering in light of a backlash against big tech companies and significant budget shortfalls as the […]
Read more
Jan. 5, 2021 – The just-enacted COVID-19 relief bill may be a harbinger of what is to come in 2021 for drug pricing and marketing tax proposals, according to Coalition for Healthcare Communication Executive Director Jon Bigelow. In a memo to Coalition members and industry leaders, Bigelow noted that it had been fairly clear weeks […]
Read more
July 27, 2020 – The four Executive Orders signed by President Trump on Friday were designed to address drug pricing concerns, but their combined impact is modest and they are “unlikely to have any immediate effect,” according to Coalition for Healthcare Communication Executive Director Jon Bigelow. However, they do “give the president talking points for […]
Read more April 6, 2020 – The Coalition for Healthcare Communication last week endorsed an urgent request to Maryland Governor Larry Hogan (R) to veto HB 732, which would put in place the nation’s first tax on digital advertising. The request, sent March 31 by national media and advertising trade associations and members of The Advertising Coalition, […]
Read more
Feb. 24, 2020 – As the country prepares for a national election on Nov. 3, the Coalition for Healthcare Communication is endorsing the nonpartisan “Time to Vote” initiative developed by a coalition of U.S. companies that seeks to ensure that all employees have a work schedule that allows them to vote in elections. “Politics is […]
Read more
Feb. 11, 2020 – John Kamp, who served for 16 years as the executive director of the Coalition for Healthcare Communication, last week was inducted into the Medical Advertising Hall of Fame (MAHF) and given the MAHF’s 2020 Service to Industry Award. “John is a wise, shrewd, and articulate defender of the First Amendment right […]
Read more
Jan. 13, 2020 — Jay Carter, RPh, has been elected Chair of the Executive Committee of the Coalition for Healthcare Communication for 2020-2021. He succeeds Karsten Risch, M.D., Ph.D., M.P.H., who served in 2018-2019. “We are in an election year where our industry will be continuously scrutinized and criticized,” said Carter. “Business as usual. I’m […]
Read more Sept. 20, 2019 – Although the House proposal unveiled by House Speaker Nancy Pelosi (D-Calif.) to combat high drug prices would cap Medicare drug prices based on the average price in six developed countries, require that the federal government and drug companies negotiate prices for up to 250 of the most expensive prescription drugs, mandate […]
Read more
May 23, 2019 – Concern over drug pricing remains a healthcare policy issue that enjoys bipartisan support and will remain on the table for the Trump administration and Congress as campaigns for the 2020 election ramp up, according to Kate Rawson, senior editor at Prevision Policy. Speaking at a session of the Coalition for Healthcare […]
Read more March 25, 2019 – Several moves that could change the way prescription drug marketing and communications are conducted are being made in Washington, with the House Ways and Means Committee about to begin markup on a tax measure that could include eliminating the deductibility of drug marketing costs, and the Office of Management and Budget […]
Read more